The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Abstract
The discovery of potent and safe antimicrobial agents is arguably the single greatest health care advance in history. The availability of these agents rapidly reduced the morbidity and mortality associated with a host of formerly fatal diseases. In addition, the confidence that infections could be prevented or treated by antibiotics allowed major leaps forward in the treatment of noninfectious diseases, including serious heart disease, cancers, and organ failure requiring transplants. Medical care, as we now know it, could not exist without the availability of effective antibiotics The widespread use of antibiotics has been associated with what we now know to be the predictable emergence of resistance. Early confidence that infections would eventually be conquered has given way to a greater appreciation of the genetic flexibility of common human pathogens. Moreover, we have come to appreciate the role played by microorganisms in our homeostasis. Microorganisms are an intrinsic part of us, and we would do well to learn to live with them
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peters, N. K., Dixon, D. M., Holland, S. M., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/533451 · Cited by 55
Cited by
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Self-citationMobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Antimicrobial Photodynamic Therapy to Kill Gram-negative Bacteria
Sperandio, F. F., Huang, Y.-Y., & Hamblin, M. R. (2014) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/1574891x113089990012 · Cited by 585
Genomic Definition of Hypervirulent and Multidrug-Resistant Klebsiella pneumoniae Clonal Groups
Bialek-Davenet, S., Criscuolo, A., Ailloud, F., Passet, V., Jones, L., Delannoy-Vieillard, A.-S., Garin, B., Le Hello, S., Arlet, G., Nicolas-Chanoine, M.-H., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140206 · Cited by 481
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Bush, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.006 · Cited by 398
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Optimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
Nguyen, A. Q., Vu, H. P., Nguyen, L. N., Wang, Q., Djordjevic, S. P., Donner, E., Yin, H., & Nghiem, L. D. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146964 · Cited by 339
Chin, W., Zhong, G., Pu, Q., Yang, C., Lou, W., De Sessions, P. F., Periaswamy, B., Lee, A., Liang, Z. C., Ding, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03325-6 · Cited by 331
A rapid antimicrobial susceptibility test based on single-cell morphological analysis
Choi, J., Yoo, J., Lee, M., Kim, E.-G., Lee, J. S., Lee, S., Joo, S., Song, S. H., Kim, E.-C., Lee, J. C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009650 · Cited by 311
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Bacteria from Animals as a Pool of Antimicrobial Resistance Genes
Argudín, M., Deplano, A., Meghraoui, A., Dodémont, M., Heinrichs, A., Denis, O., Nonhoff, C., & Roisin, S. (2017) · Antibiotics · doi:10.3390/antibiotics6020012 · Cited by 283
Puca, V., Marulli, R. Z., Grande, R., Vitale, I., Niro, A., Molinaro, G., Prezioso, S., Muraro, R., & Di Giovanni, P. (2021) · Antibiotics · doi:10.3390/antibiotics10101162 · Cited by 268
Nguyen, M., & Joshi, S. G. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15130 · Cited by 259
Antimicrobial Activity of Polyphenols and Natural Polyphenolic Extracts on Clinical Isolates
Manso, T., Lores, M., & de Miguel, T. (2021) · Antibiotics · doi:10.3390/antibiotics11010046 · Cited by 253
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
Yoon, E.-J., & Jeong, S. H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.614058 · Cited by 221
(2021) · doi:10.3322/caac.21697 · Cited by 201
Klebba, P. E., Newton, S. M. C., Six, D. A., Kumar, A., Yang, T., Nairn, B. L., Munger, C., & Chakravorty, S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01005 · Cited by 150
Sartelli, M., C. Hardcastle, T., Catena, F., Chichom-Mefire, A., Coccolini, F., Dhingra, S., Haque, M., Hodonou, A., Iskandar, K., Labricciosa, F. M., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9080497 · Cited by 149
(2015) · doi:10.1016/j.jinf.2014.10.004 · Cited by 143
Yokota, P. K. O., Marra, A. R., Martino, M. D. V., Victor, E. S., Durão, M. S., Edmond, M. B., & dos Santos, O. F. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104475 · Cited by 85
Capsules and their traits shape phage susceptibility and plasmid conjugation efficiency
Haudiquet, M., Le Bris, J., Nucci, A., Bonnin, R. A., Domingo-Calap, P., Rocha, E. P. C., & Rendueles, O. (2024) · Nature Communications · doi:10.1038/s41467-024-46147-5 · Cited by 72
Olivier, N. B., Altman, R. B., Noeske, J., Basarab, G. S., Code, E., Ferguson, A. D., Gao, N., Huang, J., Juette, M. F., Livchak, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414401111 · Cited by 48
Jo, J., Kwon, K. T., & Ko, K. S. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00914-6 · Cited by 22
Holzinger, J. M., Toelge, M., Werner, M., Ederer, K. U., Siegmund, H. I., Peterhoff, D., Blaas, S. H., Gisch, N., Brochhausen, C., Gessner, A., et al. (2023) · eLife · doi:10.7554/elife.86369 · Cited by 4
Tagliaferri, T. L., Vieira, C. D., de Carvalho, M. A. R., Ladeira, L. C. D., Magalhães, P. P., de Macêdo Farias, L., & dos Santos, S. G. (2017) · Letters in Applied Microbiology · doi:10.1111/lam.12775 · Cited by 3
Legood, S., Oliveira Paiva, A., Taib, N., Ruffiot, T., Gribaldo, S., Gomperts Boneca, I., & Buddelmeijer, N. (2026) · mBio · doi:10.1128/mbio.00600-26 · Cited by 1
Metadata
- Authors
- Rice, L. B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-15
- Volume
- 197
- Issue
- 8
- Pages
- 1079-1081
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2168519960
- Cited by
- 2,310
- References
- 1
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.